[A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002219:Carbamates / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007609:Kallidin / Q000037:antagonists & inhibitors; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use
D002219:Carbamates; D010919:Placebos; D011725:Pyridines; D007609:Kallidin